Literature DB >> 843530

The photodynamic modification of DNA by hematoporphyrin.

B Gutter, W T Speck, H S Rosenkranz.   

Abstract

Illumination (white light: 300-750 nm) of DNA in the presence of hematoporphyrin (less than or equal to 5-10 (-4) M) results in selective degradation of the guanine moiety. DNA so illuminated exhibits physical chemical properties (lowered sedimentation coefficients, lower temperatures of helix-coil transitions, increased buoyant density values) consistent with single-chain scissions (and the generation of single-stranded regions) which presumably are secondary to the photodegradation of the guanine residue. Illumination of DNA in the presence of low levels of hematoporphyrin (greater than or equal to 2.5 - 10 (-4) M) results in a biopolymer exhibiting all of the physical properties described above with the exception of a lowered sedimentation coefficient; on the contrary such DNA is aggregated. Of the four usual deoxynucleosides irradiated in the presence of hematoporphyrin, only deoxyguanosine is destroyed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843530     DOI: 10.1016/0005-2787(77)90021-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Mitochondria are targets of photodynamic therapy.

Authors:  Russell Hilf
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 2.945

2.  Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light.

Authors:  A Coppola; E Viggiani; L Salzarulo; G Rasile
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

3.  Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells.

Authors:  J R Shulok; J E Klaunig; S H Selman; P J Schafer; P J Goldblatt
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

4.  Photodynamic action and chromosomal damage: a comparison of haematoporphyrin derivative (HpD) and light with X-irradiation.

Authors:  J F Evensen; J Moan
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.